Nuveen Asset Management’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-135,134
| Closed | -$420K | – | 3270 |
|
|
2022
Q1 | $420K | Buy |
135,134
+1,137
| +0.8% | +$3.53K | ﹤0.01% | 3062 |
|
|
2021
Q4 | $594K | Sell |
133,997
-13,789
| -9% | -$61.1K | ﹤0.01% | 3027 |
|
|
2021
Q3 | $1.29M | Sell |
147,786
-4,279
| -3% | -$37.4K | ﹤0.01% | 2881 |
|
|
2021
Q2 | $1.15M | Sell |
152,065
-9,537
| -6% | -$72K | ﹤0.01% | 2957 |
|
|
2021
Q1 | $1.4M | Buy |
161,602
+921
| +0.6% | +$8K | ﹤0.01% | 2771 |
|
|
2020
Q4 | $1.28M | Buy |
160,681
+11,784
| +8% | +$93.9K | ﹤0.01% | 2714 |
|
|
2020
Q3 | $1.19M | Buy |
148,897
+7,607
| +5% | +$60.7K | ﹤0.01% | 2611 |
|
|
2020
Q2 | $1.4M | Buy |
141,290
+20,581
| +17% | +$204K | ﹤0.01% | 2479 |
|
|
2020
Q1 | $933K | Buy |
120,709
+10,311
| +9% | +$79.7K | ﹤0.01% | 2540 |
|
|
2019
Q4 | $425K | Hold |
110,398
| – | – | ﹤0.01% | 2943 |
|
|
2019
Q3 | $555K | Sell |
110,398
-6,149
| -5% | -$30.9K | ﹤0.01% | 2908 |
|
|
2019
Q2 | $770K | Buy |
+116,547
| New | +$770K | ﹤0.01% | 2843 |
|